This interaction mediated the effect of exosomes onferroptosis, suggesting that the exosomes from patients with MI (MI-Exo)/miR-26b-5p/SLC7A11/GSH/GPX4 axis mayrepresent a promising target for future treatments of AMI. This evidence concerns the gene GPX4 and myocardial infarction.